Evaluating surgeon-specific performance for endoscopic sinus surgery

Luke Rudmik, Yuan Xu, Jeremiah A. Alt, Adam Deconde, Timothy Smith, Rodney J. Schlosser, Hude Quan, Zachary M. Soler

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

IMPORTANCE: Several identified factors have raised questions concerning the quality of care for endoscopic sinus surgery (ESS), including the presence of large geographic variation in the rates and extent of surgery, poorly defined indications, and lack of ESS-specific quality metrics. Combined with the risk of major complications, ESS represents a high-value target for quality improvement. OBJECTIVE: To evaluate differences in surgeon-specific performance for ESS using a risk-adjusted, 5-year ESS revision rate as a quality metric. DESIGN, SETTING, AND PARTICIPANTS: This retrospective study used a population-based administrative database to study adults (≥18 years of age) with chronic rhinosinusitis (CRS) who underwent primary ESS in Alberta, Canada, between March 1, 2007, and March 1, 2010. The study period ended in 2015 to provide 5 years of follow-up. INTERVENTIONS: Endoscopic sinus surgery for CRS. MAIN OUTCOMES AND MEASURES: Primary outcomes were the 5-year observed and risk-adjusted ESS revision rate. Logistic regression was used to develop a risk adjustment model for the primary outcome. RESULTS A total of 43 individual surgeons performed primary ESS in 2168 patients with CRS. Within 5 years after the primary ESS procedure, 239 patients underwent revision ESS, and the mean crude 5-year ESS revision rate was 10.6% (range, 2.4%-28.6%). After applying the risk adjustment model and 95% CI to each surgeon, 7 surgeons (16%) had lower-than-expected performance and 2 surgeons (5%) had higher-than-expected performance. Three variables had significant associations with surgeon-specific, 5-year ESS revision rates: presence of nasal polyps (odds ratio [OR], 2.07; 95% CI, 1.59-2.70), more annual systemic corticosteroid courses (OR, 1.33; 95% CI, 1.19-1.48), and concurrent septoplasty (OR, 0.70; 95% CI, 0.55-0.89). CONCLUSIONS AND RELEVANCE: Evaluating surgeon-specific performance for ESS may provide information to assist in quality improvement. Although most surgeons had comparable risk-adjusted, 5-year ESS revision rates, 16% of surgeons had lower-than-expected performance, indicating a potential to improve quality of care. Future studies are needed to evaluate more surgeon-specific variables and validate a risk adjustment model to provide appropriate feedback for quality improvement.

Original languageEnglish (US)
Pages (from-to)891-898
Number of pages8
JournalJAMA Otolaryngology - Head and Neck Surgery
Volume143
Issue number9
DOIs
StatePublished - Sep 1 2017

Fingerprint

Reoperation
Risk Adjustment
Quality Improvement
Quality of Health Care
Odds Ratio
Surgeons
Nasal Polyps
Alberta
Canada
Adrenal Cortex Hormones
Retrospective Studies
Logistic Models
Outcome Assessment (Health Care)
Databases
Population

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology

Cite this

Rudmik, L., Xu, Y., Alt, J. A., Deconde, A., Smith, T., Schlosser, R. J., ... Soler, Z. M. (2017). Evaluating surgeon-specific performance for endoscopic sinus surgery. JAMA Otolaryngology - Head and Neck Surgery, 143(9), 891-898. https://doi.org/10.1001/jamaoto.2017.0752

Evaluating surgeon-specific performance for endoscopic sinus surgery. / Rudmik, Luke; Xu, Yuan; Alt, Jeremiah A.; Deconde, Adam; Smith, Timothy; Schlosser, Rodney J.; Quan, Hude; Soler, Zachary M.

In: JAMA Otolaryngology - Head and Neck Surgery, Vol. 143, No. 9, 01.09.2017, p. 891-898.

Research output: Contribution to journalArticle

Rudmik, L, Xu, Y, Alt, JA, Deconde, A, Smith, T, Schlosser, RJ, Quan, H & Soler, ZM 2017, 'Evaluating surgeon-specific performance for endoscopic sinus surgery', JAMA Otolaryngology - Head and Neck Surgery, vol. 143, no. 9, pp. 891-898. https://doi.org/10.1001/jamaoto.2017.0752
Rudmik, Luke ; Xu, Yuan ; Alt, Jeremiah A. ; Deconde, Adam ; Smith, Timothy ; Schlosser, Rodney J. ; Quan, Hude ; Soler, Zachary M. / Evaluating surgeon-specific performance for endoscopic sinus surgery. In: JAMA Otolaryngology - Head and Neck Surgery. 2017 ; Vol. 143, No. 9. pp. 891-898.
@article{316e27daf6374ebcb0675060fd89aaee,
title = "Evaluating surgeon-specific performance for endoscopic sinus surgery",
abstract = "IMPORTANCE: Several identified factors have raised questions concerning the quality of care for endoscopic sinus surgery (ESS), including the presence of large geographic variation in the rates and extent of surgery, poorly defined indications, and lack of ESS-specific quality metrics. Combined with the risk of major complications, ESS represents a high-value target for quality improvement. OBJECTIVE: To evaluate differences in surgeon-specific performance for ESS using a risk-adjusted, 5-year ESS revision rate as a quality metric. DESIGN, SETTING, AND PARTICIPANTS: This retrospective study used a population-based administrative database to study adults (≥18 years of age) with chronic rhinosinusitis (CRS) who underwent primary ESS in Alberta, Canada, between March 1, 2007, and March 1, 2010. The study period ended in 2015 to provide 5 years of follow-up. INTERVENTIONS: Endoscopic sinus surgery for CRS. MAIN OUTCOMES AND MEASURES: Primary outcomes were the 5-year observed and risk-adjusted ESS revision rate. Logistic regression was used to develop a risk adjustment model for the primary outcome. RESULTS A total of 43 individual surgeons performed primary ESS in 2168 patients with CRS. Within 5 years after the primary ESS procedure, 239 patients underwent revision ESS, and the mean crude 5-year ESS revision rate was 10.6{\%} (range, 2.4{\%}-28.6{\%}). After applying the risk adjustment model and 95{\%} CI to each surgeon, 7 surgeons (16{\%}) had lower-than-expected performance and 2 surgeons (5{\%}) had higher-than-expected performance. Three variables had significant associations with surgeon-specific, 5-year ESS revision rates: presence of nasal polyps (odds ratio [OR], 2.07; 95{\%} CI, 1.59-2.70), more annual systemic corticosteroid courses (OR, 1.33; 95{\%} CI, 1.19-1.48), and concurrent septoplasty (OR, 0.70; 95{\%} CI, 0.55-0.89). CONCLUSIONS AND RELEVANCE: Evaluating surgeon-specific performance for ESS may provide information to assist in quality improvement. Although most surgeons had comparable risk-adjusted, 5-year ESS revision rates, 16{\%} of surgeons had lower-than-expected performance, indicating a potential to improve quality of care. Future studies are needed to evaluate more surgeon-specific variables and validate a risk adjustment model to provide appropriate feedback for quality improvement.",
author = "Luke Rudmik and Yuan Xu and Alt, {Jeremiah A.} and Adam Deconde and Timothy Smith and Schlosser, {Rodney J.} and Hude Quan and Soler, {Zachary M.}",
year = "2017",
month = "9",
day = "1",
doi = "10.1001/jamaoto.2017.0752",
language = "English (US)",
volume = "143",
pages = "891--898",
journal = "JAMA Otolaryngology - Head and Neck Surgery",
issn = "2168-6181",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - Evaluating surgeon-specific performance for endoscopic sinus surgery

AU - Rudmik, Luke

AU - Xu, Yuan

AU - Alt, Jeremiah A.

AU - Deconde, Adam

AU - Smith, Timothy

AU - Schlosser, Rodney J.

AU - Quan, Hude

AU - Soler, Zachary M.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - IMPORTANCE: Several identified factors have raised questions concerning the quality of care for endoscopic sinus surgery (ESS), including the presence of large geographic variation in the rates and extent of surgery, poorly defined indications, and lack of ESS-specific quality metrics. Combined with the risk of major complications, ESS represents a high-value target for quality improvement. OBJECTIVE: To evaluate differences in surgeon-specific performance for ESS using a risk-adjusted, 5-year ESS revision rate as a quality metric. DESIGN, SETTING, AND PARTICIPANTS: This retrospective study used a population-based administrative database to study adults (≥18 years of age) with chronic rhinosinusitis (CRS) who underwent primary ESS in Alberta, Canada, between March 1, 2007, and March 1, 2010. The study period ended in 2015 to provide 5 years of follow-up. INTERVENTIONS: Endoscopic sinus surgery for CRS. MAIN OUTCOMES AND MEASURES: Primary outcomes were the 5-year observed and risk-adjusted ESS revision rate. Logistic regression was used to develop a risk adjustment model for the primary outcome. RESULTS A total of 43 individual surgeons performed primary ESS in 2168 patients with CRS. Within 5 years after the primary ESS procedure, 239 patients underwent revision ESS, and the mean crude 5-year ESS revision rate was 10.6% (range, 2.4%-28.6%). After applying the risk adjustment model and 95% CI to each surgeon, 7 surgeons (16%) had lower-than-expected performance and 2 surgeons (5%) had higher-than-expected performance. Three variables had significant associations with surgeon-specific, 5-year ESS revision rates: presence of nasal polyps (odds ratio [OR], 2.07; 95% CI, 1.59-2.70), more annual systemic corticosteroid courses (OR, 1.33; 95% CI, 1.19-1.48), and concurrent septoplasty (OR, 0.70; 95% CI, 0.55-0.89). CONCLUSIONS AND RELEVANCE: Evaluating surgeon-specific performance for ESS may provide information to assist in quality improvement. Although most surgeons had comparable risk-adjusted, 5-year ESS revision rates, 16% of surgeons had lower-than-expected performance, indicating a potential to improve quality of care. Future studies are needed to evaluate more surgeon-specific variables and validate a risk adjustment model to provide appropriate feedback for quality improvement.

AB - IMPORTANCE: Several identified factors have raised questions concerning the quality of care for endoscopic sinus surgery (ESS), including the presence of large geographic variation in the rates and extent of surgery, poorly defined indications, and lack of ESS-specific quality metrics. Combined with the risk of major complications, ESS represents a high-value target for quality improvement. OBJECTIVE: To evaluate differences in surgeon-specific performance for ESS using a risk-adjusted, 5-year ESS revision rate as a quality metric. DESIGN, SETTING, AND PARTICIPANTS: This retrospective study used a population-based administrative database to study adults (≥18 years of age) with chronic rhinosinusitis (CRS) who underwent primary ESS in Alberta, Canada, between March 1, 2007, and March 1, 2010. The study period ended in 2015 to provide 5 years of follow-up. INTERVENTIONS: Endoscopic sinus surgery for CRS. MAIN OUTCOMES AND MEASURES: Primary outcomes were the 5-year observed and risk-adjusted ESS revision rate. Logistic regression was used to develop a risk adjustment model for the primary outcome. RESULTS A total of 43 individual surgeons performed primary ESS in 2168 patients with CRS. Within 5 years after the primary ESS procedure, 239 patients underwent revision ESS, and the mean crude 5-year ESS revision rate was 10.6% (range, 2.4%-28.6%). After applying the risk adjustment model and 95% CI to each surgeon, 7 surgeons (16%) had lower-than-expected performance and 2 surgeons (5%) had higher-than-expected performance. Three variables had significant associations with surgeon-specific, 5-year ESS revision rates: presence of nasal polyps (odds ratio [OR], 2.07; 95% CI, 1.59-2.70), more annual systemic corticosteroid courses (OR, 1.33; 95% CI, 1.19-1.48), and concurrent septoplasty (OR, 0.70; 95% CI, 0.55-0.89). CONCLUSIONS AND RELEVANCE: Evaluating surgeon-specific performance for ESS may provide information to assist in quality improvement. Although most surgeons had comparable risk-adjusted, 5-year ESS revision rates, 16% of surgeons had lower-than-expected performance, indicating a potential to improve quality of care. Future studies are needed to evaluate more surgeon-specific variables and validate a risk adjustment model to provide appropriate feedback for quality improvement.

UR - http://www.scopus.com/inward/record.url?scp=85029870940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029870940&partnerID=8YFLogxK

U2 - 10.1001/jamaoto.2017.0752

DO - 10.1001/jamaoto.2017.0752

M3 - Article

C2 - 28655057

AN - SCOPUS:85029870940

VL - 143

SP - 891

EP - 898

JO - JAMA Otolaryngology - Head and Neck Surgery

JF - JAMA Otolaryngology - Head and Neck Surgery

SN - 2168-6181

IS - 9

ER -